BPC?157 is a synthetic pentadecapeptide originally identified as a fragment of a naturally occurring protein in human gastric juice. This peptide exhibits outstanding stability in acidic environments such as gastric fluid, which differentiates it from many other fragile peptide molecules. It has been widely used in preclinical laboratory research focusing on tissue repair, cytoprotection and inflammatory regulation. In research models, BPC?157 is observed to modulate angiogenesis, support endothelial cell migration, promote the repair of tendons, ligaments, muscles and joint soft tissues, and exert protective effects on gastrointestinal mucosa. It also participates in regulating local inflammatory responses, reducing excessive oxidative stress and supporting wound healing processes. Our BPC?157 is produced by solid-phase peptide synthesis, purified by preparative HPLC, and undergoes strict HPLC and MS quality verification for each batch to guarantee high purity, low residual solvent and consistent batch-to-batch performance. The lyophilized form effectively protects the peptide structure and biological activity during transportation and long-term storage. After reconstitution with appropriate solvent, it can be used for in-vitro and animal research trials only.